In vitro study of triphala ointment and randomized control trial of triphala ointment in leucorrhoea (shwetapradar): A conceptual study
International Journal of Drug Delivery Technology · 30.05.2026 · 16 (37s)
DOI: 10.25258/ijddt.16.37s.124 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 30.05.2026. Verfasst von Rahul Gajare und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Women’s health has always been a significant concern in both modern and traditional medical systems. Among the most commonly reported gynecological symptoms is Leucorrhoea, or excessive vaginal discharge, which may be physiological or pathological in origin. In Ayurveda, a condition analogous to Leucorrhoea is referred to as Shwetapradar, characterized by the discharge of white, odorless, slimy fluid from the vaginal canal, mainly due to the prakop of Kapha and Apana Vata. Shwetapradar is frequently seen in women of reproductive age and can be influenced by factors such as improper dietary habits, sedentary lifestyle, stress, hormonal changes, and unhygienic practices. While physiological discharge maintains vaginal moisture and pH, pathological discharge may be due to infections (fungal, bacterial, or protozoal), cervicitis, or hormonal disturbances. In modern medicine, Clotrimazole, a broad-spectrum antifungal agent, is widely used for treating candidal vaginitis. However, its prolonged use may lead to recurrence, resistance, and side effects such as irritation or local burning. Triphala—a classical combination of Haritaki, Bibhitaki, and Amalaki—possesses antimicrobial, anti-inflammatory, astringent, Rasayana, and wound-healing properties, making it suitable for local vaginal application. The comparative evaluation of Triphala and Clotrimazole in the management of leucorrhoea is significant for integrating evidence-based traditional medicine into modern clinical practice. By combining clinical observations with preclinical studies, including in vitro antifungal assays and mechanistic insights, a more comprehensive understanding of Triphala’s therapeutic action can be established.
Zitieren
APA
Gajare, R., & Potdar, V. J. (2026). In vitro study of triphala ointment and randomized control trial of triphala ointment in leucorrhoea (shwetapradar): A conceptual study. International Journal of Drug Delivery Technology, 16(37s). https://doi.org/10.25258/ijddt.16.37s.124
Vancouver
Gajare R, Potdar VJ. In vitro study of triphala ointment and randomized control trial of triphala ointment in leucorrhoea (shwetapradar): A conceptual study. International Journal of Drug Delivery Technology. 2026;16(37s). doi:10.25258/ijddt.16.37s.124
BibTeX
@article{Gajare2026,
author = {Gajare, Rahul and Potdar, Vaishnavi J.},
title = {In vitro study of triphala ointment and randomized control trial of triphala ointment in leucorrhoea (shwetapradar): A conceptual study},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {37s},
doi = {10.25258/ijddt.16.37s.124}
}
EUVIMED